- Eptinezumab - the new anti-CGRP monoclonal antibody for prophylactic treatment of migraine2022 | Faculty of Medicine in Pilsen
- CGRP monoclonal antibodies for migraine prophylaxis2019 | First Faculty of Medicine
- From pathophysiology of migraine to monoclonal antibodies2019 | Faculty of Medicine in Pilsen
- Primary headaches - treatment today and tomorrow2018 | Faculty of Medicine in Pilsen
